HFE, G., JE, P., R, K., & RK, S. (2019). Fibrosis driving myofibroblast precursors in MPN and new therapeutic pathways. HemaSphere, 3(Suppl), . https://doi.org/10.1097/HS9.0000000000000216
Chicago Style (17th ed.) CitationHFE, Gleitz, Pritchard JE, Kramann R, and Schneider RK. "Fibrosis Driving Myofibroblast Precursors in MPN and New Therapeutic Pathways." HemaSphere 3, no. Suppl (2019). https://doi.org/10.1097/HS9.0000000000000216.
MLA (9th ed.) CitationHFE, Gleitz, et al. "Fibrosis Driving Myofibroblast Precursors in MPN and New Therapeutic Pathways." HemaSphere, vol. 3, no. Suppl, 2019, https://doi.org/10.1097/HS9.0000000000000216.
Warning: These citations may not always be 100% accurate.